Trial intelligence / Profile preview

GIM4: Letrozole Duration in Post-Menopausal Early Breast Cancer

NCT01064635Phase 3Active, not recruiting

Start
Aug 2005
Primary completion
Aug 2015
Modality
Orthosteric Ligands
Countries
1
01

Overview

A Phase 3 trial of letrozole in breast cancer. Started Aug 2005; status: active, not recruiting.

02

Drugs

letrozole
03

Conditions

breast cancer

Beyond the preview

Go deeper on NCT01064635.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01064635.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call